Series B - Alphamab Oncology
Investment Firm
Overview
Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization.
Announced Date
May 28, 2019
Funding Type
Series B
Highlights
Location
Asia
Social
Investor Lead
N/A
Participant Investors
5
Round Details and Background
Alphamab Oncology raised $60000000 on 2019-05-28 in Series B
Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization.
Company Funding History
2
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Nov 16, 2018 |  Series A - Alphamab Oncology | 6 | - | 100.0M |
| May 28, 2019 | Series B - Alphamab Oncology | 5 | - | 60.0M |
Recent Activity
There is no recent news or activity for this profile.